This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
3 www.kimr.co.kr
목 차2012 바이오산업 분야별 시장동향과 유망기술 개발전략
Ⅰ. 바이오산업 동향 ··········································································· 311. 바이오산업 분류 정의 ··············································································31
2) 고령친화 의료기기 련 기업 일반 황 업실 ··································343
7. 첨단 상진단기기 시장과 기술개발 동향 ················································355
1) 첨단 상진단기기 시장과 특허 출원 동향 ······················································355
2) 첨단 상진단기기 련 기업 일반 황 업실 ····································357
6 한국산업마 연구소
Ⅺ. 부록 - 유망 바이오 기술 개발 현황 ····································· 3691. 유망 바이오 기술 개발 로드맵 ··································································369
[표Ⅴ-15] 기타 바이오환경제품 서비스 시장규모 추이 (단 : 백만원) ····················162
Ⅵ. 바이오전자산업 동향 ································································· 167[표Ⅵ-1] 바이오 자 주력 기업 추이 (단 : 개, %) ····························································167
[표Ⅵ-2] 바이오 자 주력 기업 지역별 분포 추이 (단 : 개) ··········································168
[표Ⅵ-3] 바이오 자 주력 기업의 인력 황 추이 (단 : 명) ············································168
[표Ⅵ-4] 바이오 자 주력 기업의 연구개발비 추이 (단 : 백만원, %) ··························169
[표Ⅵ-5] 바이오 자 주력 기업의 시설투자비 추이 (단 : 백만원, %) ··························169
[표Ⅵ-6] 바이오 자 시장규모 추이 (단 : 백만원) ····························································170
[표Ⅵ-7] 바이오 자 품목별 시장규모 추이 (단 : 백만원) ··············································172
[표Ⅵ-8] 바이오 자 품목별 국내 매 추이 (단 : 백만원) ············································173
[표Ⅵ-9] 바이오 자 품목별 수출 추이 (단 : 백만원) ······················································176
[표Ⅵ-10] 바이오 자 품목별 수입 추이 (단 : 백만원) ····················································177
[표Ⅹ-2] 이피엑스그린 미칼(주) 기업 황 업 실 ···········································281
[표Ⅹ-3] 상(주) 기업 황 업 실 ···········································································282
[표Ⅹ-4] (주) 우건설 기업 황 업 실 ···································································282
[표Ⅹ-5] (주)동부한농 기업 황 업 실 ···································································283
[표Ⅹ-6] (주)두원정공 기업 황 업 실 ···································································284
[표Ⅹ-7] (주)바이오트론 기업 황 업 실 ·······························································284
[표Ⅹ-8] 삼성물산(주) 기업 황 업 실 ···································································285
[표Ⅹ-9] (주)에코에 지홀딩스 기업 황 업 실 ···················································285
[표Ⅹ-10] 서 주정(주) 기업 황 업 실 ·································································286
[표Ⅹ-11] 애경유화(주) 기업 황 업 실 ·································································287
[표Ⅹ-12] (주)에코솔루션 기업 황 업 실 ·····························································287
[표Ⅹ-13] (주)엠에 지 기업 황 업 실 ·································································288
[표Ⅹ-14] 일산실업(주) 기업 황 업 실 ·································································289
[표Ⅹ-15] 제이씨 미칼(주) 기업 황 업 실 ·························································289
[표Ⅹ-16] (주)지앤지인텍 기업 황 업 실 ·····························································290
[표Ⅹ-17] (주)진로발효 기업 황 업 실 ·································································290
[표Ⅹ-18] (주)창해에탄올 기업 황 업 실 ·····························································291
[표Ⅹ-19] 코오롱 로벌(주) 기업 황 업 실 ·························································292
[표Ⅹ-20] (주)포스코 기업 황 업 실 ·····································································292
[표Ⅹ-21] 한라건설(주) 기업 황 업 실 ·································································293
[표Ⅹ-22] (주)비디 이 기업 황 업 실 ·································································294
[표Ⅹ-23] 지에스건설(주) 기업 황 업 실 ·····························································294
[표Ⅹ-24] 지에스칼텍스(주) 기업 황 업 실 ·························································295
[표Ⅹ-25] SK에 지(주) 기업 황 업 실 ································································295
[표Ⅹ-26] 구주제약(주) 기업 황 업 실 ·································································299
[표Ⅹ-27] 근화제약(주) 기업 황 업 실 ·································································299
[표Ⅹ-28] (주)녹십자 기업 황 업 실 ·····································································300
[표Ⅹ-29] 동아제약(주) 기업 황 업 실 ·································································301
[표Ⅹ-30] 메디포스트(주) 기업 황 업 실 ·····························································301
[표Ⅹ-31] (주)바이넥스 기업 황 업 실 ·································································302
[표Ⅹ-32] (주)바이로메드 기업 황 업 실 ·····························································303
15 www.kimr.co.kr
[표Ⅹ-33] (주)바이오톡스텍 기업 황 업 실 ·························································303
[표Ⅹ-34] 부 약품(주) 기업 황 업 실 ·································································304
[표Ⅹ-35] (주)서울제약 기업 황 업 실 ·································································305
[표Ⅹ-36] 세원셀론텍(주) 기업 황 업 실 ·····························································305
[표Ⅹ-37] (주)셀트리온 기업 황 업 실 ·································································306
[표Ⅹ-38] (주)아미팜 기업 황 업 실 ·····································································307
[표Ⅹ-39] 안국약품(주) 기업 황 업 실 ·································································307
[표Ⅹ-40] (주)앱자인 기업 황 업 실 ·····································································308
[표Ⅹ-41] (주)이노셀 기업 황 업 실 ·····································································308
[표Ⅹ-42] 일동제약(주) 기업 황 업 실 ·································································309
[표Ⅹ-43] (주)제넥신 기업 황 업 실 ·····································································310
[표Ⅹ-44] (주)종근당 기업 황 업 실 ·····································································310
[표Ⅹ-45] 제이더블유 외제약(주) 기업 황 업 실 ·············································311
[표Ⅹ-46] 크리스탈지노믹스(주) 기업 황 업 실 ·················································312
[표Ⅹ-47] 한화 미칼(주) 기업 황 업 실 ·····························································312
[표Ⅹ-48] (주)에이앤씨바이오 기업 황 업 실 ·····················································313
[표Ⅹ-49] (주)엘지생명과학 기업 황 업 실 ·························································314
[표Ⅹ-50] (주)그린바이오텍 기업 황 업 실 ·························································317
[표Ⅹ-51] (주)그린 미칼 기업 황 업 실 ·····························································317
[표Ⅹ-52] (주)나이벡 기업 황 업 실 ·····································································318
[표Ⅹ-53] (주)동부한농 기업 황 업 실 ·································································318
[표Ⅹ-54] (주)라이 코드 기업 황 업 실 ·····························································319
[표Ⅹ-55] (주)옵티팜솔루션 기업 황 업 실 ·························································320
[표Ⅹ-56] (주)바이오랜드 기업 황 업 실 ·····························································320
[표Ⅹ-57] 바이오스펙트럼(주) 기업 황 업 실 ·····················································321
[표Ⅹ-58] (주)슈가버블 기업 황 업 실 ·································································321
[표Ⅹ-59] (주)아모 퍼시픽 기업 황 업 실 ·························································322
[표Ⅹ-60] (주)엠젠 기업 황 업 실 ·········································································322
[표Ⅹ-61] (주)올메디쿠스 기업 황 업 실 ·····························································323
[표Ⅹ-62] (주)인트론바이오테크놀로지 기업 황 업 실 ·····································323
[표Ⅹ-63] 조아제약(주) 기업 황 업 실 ·································································324
[표Ⅹ-64] (주)코리아본뱅크 기업 황 업 실 ·························································325
[표Ⅹ-65] (주)휴비스 기업 황 업 실 ·····································································325
[표Ⅹ-66] 씨제이제일제당(주) 기업 황 업 실 ·····················································326
[표Ⅹ-67] (주)엘지생활건강 기업 황 업 실 ·························································327
[표Ⅹ-68] (주)한국로슈 기업 황 업 실 ·································································327
[표Ⅹ-69] 굿젠(주) 기업 황 업 실 ·········································································331
[표Ⅹ-70] 나루다이텍(주) 기업 황 업 실 ·····························································331
[표Ⅹ-71] (주)녹십자 기업 황 업 실 ·····································································332
[표Ⅹ-72] 동아제약(주) 기업 황 업 실 ·································································333
[표Ⅹ-73] (주)마크로젠 기업 황 업 실 ·································································333
16 한국산업마 연구소
[표Ⅹ-74] 바디텍메드(주) 기업 황 업 실 ·····························································334
[표Ⅹ-75] (주)바이오니아 기업 황 업 실 ·····························································334
[표Ⅹ-76] (주)바이오메드랩 기업 황 업 실 ·························································335
[표Ⅹ-77] 삼성 자(주) 기업 황 업 실 ·································································336
[표Ⅹ-78] (주)씨젠 기업 황 업 실 ·········································································336
[표Ⅹ-79] (주)아이센스 기업 황 업 실 ·································································337
[표Ⅹ-80] (주)아이소텍 기업 황 업 실 ·································································338
[표Ⅹ-81] (주)에스디 기업 황 업 실 ·····································································338
[표Ⅹ-82] (주)올메디쿠스 기업 황 업 실 ·····························································339
[표Ⅹ-83] (주)인포피아 기업 황 업 실 ·································································339
[표Ⅹ-84] (주)지노믹트리 기업 황 업 실 ·····························································340
[표Ⅹ-85] (주)엘지생명과학 기업 황 업 실 ·························································340
[표Ⅹ-86] (주)건융아이비씨 기업 황 업 실 ·························································343
[표Ⅹ-87] 성공업(주) 기업 황 업 실 ·································································344
[표Ⅹ-88] (주) 성마리 기업 황 업 실 ·····························································345
[표Ⅹ-89] 요메디(주) 기업 황 업 실 ·································································345
[표Ⅹ-90] 한보청기(주) 기업 황 업 실 ·····························································346
[표Ⅹ-91] (주)메디아나 기업 황 업 실 ·································································346
[표Ⅹ-92] (주)미건의료기 기업 황 업 실 ·····························································347
[표Ⅹ-93] (주)바이오넷 기업 황 업 실 ·································································347
[표Ⅹ-94] (주)비트컴퓨터 기업 황 업 실 ·····························································348
[표Ⅹ-95] (주)삼주유니콘 기업 황 업 실 ·····························································349
[표Ⅹ-96] (주)성우특장 기업 황 업 실 ·································································349
[표Ⅹ-97] (주)솔고바이오메디칼 기업 황 업 실 ·················································349
[표Ⅹ-98] (주)스타키코리아 기업 황 업 실 ·························································350
[표Ⅹ-99] (주)썸텍 기업 황 업 실 ·········································································351
[표Ⅹ-100] (주)엔텍 기업 황 업 실 ·······································································351
[표Ⅹ-101] (주)유비 어 기업 황 업 실 ·······························································352
[표Ⅹ-102] (주)코 텍 기업 황 업 실 ···································································352
[표Ⅹ-103] (주)퓨런메디칼 기업 황 업 실 ···························································353
[표Ⅹ-104] (주)한국보청기 기업 황 업 실 ···························································353
[표Ⅹ-105] (주)휴 기업 황 업 실 ···································································354
[표Ⅹ-106] (주)휴비딕 기업 황 업 실 ···································································354
[표Ⅹ-107] (주)디알텍 기업 황 업 실 ···································································357
[표Ⅹ-108] (주)리스템 기업 황 업 실 ···································································358
[표Ⅹ-109] 메디퓨처(주) 기업 황 업 실 ·······························································358
[표Ⅹ-110] (주)바이오넷 기업 황 업 실 ·······························································359
[표Ⅹ-111] (주)바텍 기업 황 업 실 ·······································································359
[표Ⅹ-112] 삼성모바일디스 이(주) 기업 황 업 실 ·······································360
[표Ⅹ-113] (주)사이버메드 기업 황 업 실 ···························································361
[표Ⅹ-114] (주)세 엔디씨 기업 황 업 실 ···························································361
17 www.kimr.co.kr
[표Ⅹ-115] (주)휴먼스캔 기업 황 업 실 ·······························································361
[표Ⅹ-116] (주)에코 이 기업 황 업 실 ·······························································362
[표Ⅹ-117] (주)에코트론 기업 황 업 실 ·······························································362
[표Ⅹ-118] (주)정원정 기업 황 업 실 ·······························································363
[표Ⅹ-119] (주)제노 이 기업 황 업 실 ·······························································363
[표Ⅹ-120] (주)제이더블유 외메디칼 기업 황 업 실 ·······································364
[표Ⅹ-121] 지멘스(주) 기업 황 업 실 ···································································364
[표Ⅹ-122] (주)포스콤 기업 황 업 실 ···································································365
[표Ⅹ-123] (주)피제이 자 기업 황 업 실 ···························································366
[표Ⅹ-124] (주) 의료기기 기업 황 업 실 ·······················································366
Ⅺ. 부록 - 유망 바이오 기술 개발 현황 ····································· 369[표Ⅺ-1] 바이오디젤 핵심요소기술 연구 목표 ······································································369
[표Ⅺ-2] 바이오에탄올 핵심요소기술 연구 목표 ··································································370
[표Ⅺ-3] 바이오매스가스 핵심요소기술 연구 목표 ······························································371
[표Ⅺ-4] 유 자 재조합 의약품 핵심요소기술 연구 목표 ··················································372
[표Ⅺ-5] 세포치료제 핵심요소기술 연구 목표 ······································································373
[표Ⅺ-6] 개량신약 핵심요소기술 연구 목표 ··········································································374
[표Ⅺ-7] 천연물의약품 핵심요소기술 연구 목표 ··································································375
[표Ⅺ-8] 바이오화장품 소재 핵심요소기술 연구 목표 ························································376
[표Ⅺ-9] 의료용 생체유래소재 핵심요소기술 연구 목표 ····················································377
[표Ⅺ-10] 친환경농업소재 핵심요소기술 연구 목표 ····························································378
[표Ⅺ-11] 소형 감염성 질환 만성질환 진단기 핵심요소기술 연구 목표 ··················379
[표Ⅺ-12] 표 지향 진단 치료용 소재 핵심요소기술 연구 목표 ······························381
[표Ⅺ-13] 재활 물리치료기기 핵심요소기술 연구 목표 ················································382
[표Ⅺ-14] 이동지원기기 핵심요소기술 연구 목표 ································································383
[표Ⅺ-15] 이동지원기기 핵심요소기술 연구 목표 ································································384
[표Ⅺ-16] 생체신호계측기기 핵심요소기술 연구 목표 ························································385
[표Ⅺ-17] 유방암 상진단기기 핵심요소기술 연구 목표 ··················································386
[표Ⅺ-18] 음 상진단기기 핵심요소기술 연구 목표 ··················································388
[표Ⅺ-19] 치과용 상진단기기 핵심요소기술 연구 목표 ··················································389
[표Ⅺ-20] 키랄의약 바이오의약 제조 품질분석용 키랄칼럼 신소재 개발 사업 개요 ························ 390
[표Ⅺ-21] 산업용 자 제습기 (바이오 인큐베이터) 개발 사업 개요 ······················································· 390
[표Ⅺ-22] 작물의 건 육모 토양병해 방효과를 갖는 환경친화형 바이오상토 개발 사업 개요 ··········· 390
[표Ⅺ-23] 스코리아(Scoria) 바이오 필터 개발 사업 개요 ········································································ 391
[표Ⅺ-24] 량생산형 화학/바이오 센서 계측기 개발 사업 개요 ························································· 391
[표Ⅺ-25] 바이오좀 공법을 이용한 화장품의 개발 사업 개요 ·································································· 392
[표Ⅺ-26] 아세틸콜린효소 치매유발단백질응집 해작용이 있는 생약을 이용한 치매 방
치료효능의 바이오 식품개발 사업 개요 ·················································································· 392
[표Ⅺ-27] 반도체, 바이오 산업용 순수 제조장치 개발 사업 개요 ························································· 393
[표Ⅺ-28] 가 티푸스 억제 신기능 로바이오틱스 미생물 제제개발 사업 개요 ······································· 393
18 한국산업마 연구소
[표Ⅺ-29] 토양악화 방지 지력보호용 바이오 비료생산 기술개발 사업 개요 ········································ 393
[표Ⅺ-30] 천연 물질이 함유된 생균제 바이오피드의 제조기술 개발 생산 사업 개요 ·························· 394
[표Ⅺ-31] 토양악화 방지 지력보호용 바이오 비료 생산기술 사업 개요 ··············································· 394
[표Ⅺ-32] 표면코 처리된 바이오폴리머에 의한 단백질 분리정제용 친화성 크로마토그래피 담체개발
사업 개요 ····························································································································· 395
[표Ⅺ-33] 식 독균 신속검출용 어 이형 바이오센서 개발 사업 개요 ····················································· 395
[표Ⅺ-34] 콜라겐을 이용한 바이오 매트릭스 개발 사업 개요 ·································································· 395
[표Ⅺ-35] 유방암 련 유용 바이오마커 발굴 진단 소 트웨어 개발 사업 개요 ··································· 396
[표Ⅺ-36] 장진단용 뇌/심 계 질환 다지표 바이오센서의 개발 사업 개요 ········································· 396
[표Ⅺ-37] 표면 라즈몬공명을 이용한 바이오칩 분석기기의 개발 사업 개요 ··········································· 397
[표Ⅺ-38] 동충화 를 주원료로 하는 항당뇨 바이오식품의 개발 과학 검증 개발 사업 개요 ············· 397
[표Ⅺ-39] 활성탄, 제올라이트 동시 발포 고분자 담체의 개발과 이를 이용한 바이오필터에서의 악취가스 제거
미생물 분포 특성 연구 개발 사업 개요 ············································································· 397
[표Ⅺ-40] 기능성 바이오 청국장 제품개발 사업 개요 ············································································· 398
[표Ⅺ-41] 바이오센서를 이용한 무채 당 측정 시스템 개발 사업 개요 ··············································· 398
[표Ⅺ-42] 아토피질병 억제 신기능 로바이오틱스 산업화 연구 개발 사업 개요 ····································· 398
[표Ⅺ-43] 건축용 바이오 세라믹 온돌마루 착제 개발 사업 개요 ·························································· 398
[표Ⅺ-44] 바이오 세라믹이 코 된 주방용품(화이버 쟁반)의 개발 사업 개요 ··········································· 399
[표Ⅺ-101] 속 방사능 원소 90% 이상 제거 가능한 자원순환형 친환경 바이오필터 개발사업개요 ·· 433
[표Ⅺ-102] 로바이오틱 유산균 활용, 발효 기술을 이용한 마(산약)의 다이어트 련 기능성화 식품개발
사업 개요 ··························································································································· 433
20 한국산업마 연구소
[표Ⅺ-103] 고해상도 바이오 메디컬 이미징을 한 형 공 미경 개발 사업 개요 ·························· 434
[표Ⅺ-104] N-말단기 치특이 페길 이션 기술을 활용한 바이오베터 개발 (VEGF-Trap) 사업 개요 ··· 435
[표Ⅺ-105] 상온유통이 가능한 바이오의약품(단백질, 항체) 약물 달 랫폼 개발 사업 개요 ··············· 436
21 www.kimr.co.kr
그림 목차2012 바이오산업 분야별 시장동향과 유망기술 개발전략
Ⅰ. 바이오산업 동향 ··········································································· 31[그림Ⅰ-1] 바이오산업 분류 ········································································································31
[그림Ⅰ-2] 바이오산업 시장 규모 (단 : 백만원) ··································································32
[그림Ⅰ-3] 바이오산업 분야별 시장 유율 (단 : 백만원) ··················································33
[그림Ⅰ-4] 바이오산업 분야별 포지셔닝 - 2010년 ································································35
[그림Ⅰ-5] 바이오산업 분야별 국내 매 유율 (단 : 백만원) ······································36
[그림Ⅰ-6] 바이오산업 분야별 국내시장 포지셔닝 - 2010년 ··············································38
[그림Ⅰ-7] 바이오산업 분야별 수출 유율 (단 : 백만원) ················································39
[그림Ⅰ-8] 바이오산업 분야별 수출 포지셔닝 - 2010년 ······················································40
[그림Ⅰ-9] 바이오산업 분야별 수입 유율 (단 : 백만원) ················································41
[그림Ⅰ-10] 바이오산업 분야별 수입 포지셔닝 - 2010년 ····················································43
Ⅱ. 바이오의약산업 동향 ··································································· 47[그림Ⅱ-1] 바이오의약산업 분류 ································································································47
[그림Ⅱ-2] 바이오의약품 시장 규모 (단 : 백만원) ······························································50
[그림Ⅱ-3] 바이오의약품 분야별 시장 유율 (단 : 백만원) ··············································51
[그림Ⅱ-4] 바이오의약품 시장 분야별 포지셔닝 - 2010년 ··················································53
[그림Ⅱ-5] 바이오의약품 분야별 국내 매 유율 (단 : 백만원) ··································53
[그림Ⅱ-6] 바이오의약품 분야별 국내 매 포지셔닝 - 2010년 ········································55
[그림Ⅱ-7] 바이오의약품 분야별 수출 유율 (단 : 백만원) ············································56
[그림Ⅱ-8] 바이오의약품 분야별 수출 포지셔닝 - 2010년 ··················································58
[그림Ⅱ-9] 바이오의약품 분야별 수입 유율 (단 : 백만원) ············································58
[그림Ⅱ-10] 바이오의약품 분야별 수입 포지셔닝 - 2010년 ················································60
[그림Ⅱ-11] 항생제 시장 규모 (단 : 백만원) ········································································61
[그림Ⅱ-12] 항생제 시장 연도별 포지셔닝 ··············································································62
[그림Ⅱ-13] 항암제 시장 규모 (단 : 백만원) ········································································63
[그림Ⅱ-14] 항암제 시장 연도별 포지셔닝 ··············································································64
[그림Ⅱ-15] 백신 시장 규모 (단 : 백만원) ············································································65
[그림Ⅱ-16] 백신 시장 연도별 포지셔닝 ··················································································66
[그림Ⅱ-17] 호르몬제 시장 규모 (단 : 백만원) ····································································67
[그림Ⅱ-18] 호르몬제 시장 연도별 포지셔닝 ··········································································68
[그림Ⅱ-19] 면역제제 시장 규모 (단 : 백만원) ····································································69
22 한국산업마 연구소
[그림Ⅱ-20] 면역제제 시장 연도별 포지셔닝 ··········································································70
[그림Ⅱ-21] 액제제 시장 규모 (단 : 백만원) ····································································71
[그림Ⅱ-22] 액제제 시장 연도별 포지셔닝 ··········································································72
[그림Ⅱ-23] 성장인자 시장 규모 (단 : 백만원) ····································································73
[그림Ⅱ-24] 성장인자 시장 연도별 포지셔닝 ··········································································74
[그림Ⅱ-25] 신개념치료제 시장 규모 (단 : 백만원) ····························································75
[그림Ⅱ-26] 신개념치료제 시장 연도별 포지셔닝 ··································································76
[그림Ⅱ-27] 진단키트 시장 규모 (단 : 백만원) ····································································77
[그림Ⅱ-28] 진단키트 시장 연도별 포지셔닝 ··········································································78
[그림Ⅱ-29] 동물약품 시장 규모 (단 : 백만원) ····································································79
[그림Ⅱ-30] 동물약품 시장 연도별 포지셔닝 ··········································································80
[그림Ⅱ-31] 기타 바이오의약품 시장 연도별 포지셔닝 ························································81
Ⅲ. 바이오화학산업 동향 ··································································· 85[그림Ⅲ-1] 바이오화학산업 분류 ································································································85
[그림Ⅲ-2] 바이오화학 시장 규모 (단 : 백만원) ··································································88
[그림Ⅲ-3] 바이오화학 분야별 시장 유율 (단 : 백만원) ··················································89
[그림Ⅲ-4] 바이오화학 시장 분야별 포지셔닝 - 2010년 ······················································91
[그림Ⅲ-5] 바이오화학 분야별 국내 매 유율 (단 : 백만원) ······································91
[그림Ⅲ-6] 바이오화학 분야별 국내 매 포지셔닝 - 2010년 ············································93
[그림Ⅲ-7] 바이오화학 분야별 수출 유율 (단 : 백만원) ················································94
[그림Ⅲ-8] 바이오화학 분야별 수출 포지셔닝 - 2010년 ······················································95
[그림Ⅲ-9] 바이오화학 분야별 수입 유율 (단 : 백만원) ················································96
[그림Ⅲ-10] 바이오화학 분야별 수입 포지셔닝 - 2010년 ····················································98
[그림Ⅲ-11] 바이오고분자 시장 규모 (단 : 백만원) ····························································99
[그림Ⅲ-12] 바이오고분자 시장 연도별 포지셔닝 ································································100
[그림Ⅲ-13] 산업용효소 시약류 시장 규모 (단 : 백만원) ··········································101
[그림Ⅲ-14] 산업용효소 시약류 시장 연도별 포지셔닝 ················································102
[그림Ⅲ-15] 연구실험용 효소 시약류 시장 규모 (단 : 백만원) ································103
[그림Ⅲ-16] 연구실험용 효소 시약류 시장 연도별 포지셔닝 ······································104
[그림Ⅲ-17] 바이오화장품 생활화학제품 시장 규모 (단 : 백만원) ··························105
[그림Ⅲ-18] 바이오화장품 생활화학제품 시장 연도별 포지셔닝 ································106
[그림Ⅲ-19] 바이오농약 비료 시장 규모 (단 : 백만원) ··············································107
[그림Ⅲ-20] 바이오농약 비료 시장 연도별 포지셔닝 ····················································108
[그림Ⅲ-21] 기타 바이오화학제품 시장 규모 (단 : 백만원) ············································109
[그림Ⅲ-22] 기타 바이오화학제품 시장 연도별 포지셔닝 ··················································110
Ⅳ. 바이오식품산업 동향 ································································· 113[그림Ⅳ-1] 바이오식품산업 분류 ······························································································113
[그림Ⅳ-2] 바이오식품 시장 규모 (단 : 백만원) ································································116
23 www.kimr.co.kr
[그림Ⅳ-3] 바이오식품 분야별 시장 유율 (단 : 백만원) ················································117
[그림Ⅳ-4] 바이오식품 시장 분야별 포지셔닝 - 2010년 ····················································118
[그림Ⅳ-5] 바이오식품 분야별 국내 매 유율 (단 : 백만원) ····································119
[그림Ⅳ-6] 바이오식품 분야별 국내 매 포지셔닝 - 2010년 ··········································121
[그림Ⅳ-7] 바이오식품 분야별 수출 유율 (단 : 백만원) ··············································121
[그림Ⅳ-8] 바이오식품 분야별 수출 포지셔닝 - 2010년 ····················································123
[그림Ⅳ-9] 바이오식품 분야별 수입 유율 (단 : 백만원) ··············································123
[그림Ⅳ-10] 바이오식품 분야별 수입 포지셔닝 - 2010년 ··················································125
[그림Ⅳ-11] 건강기능식품 시장 규모 (단 : 백만원) ··························································126
[그림Ⅳ-12] 건강기능식품 시장 연도별 포지셔닝 ································································127
[그림Ⅳ-13] 아미노산 시장 규모 (단 : 백만원) ··································································128
[그림Ⅳ-14] 아미노산 시장 연도별 포지셔닝 ········································································129
[그림Ⅳ-15] 식품첨가물 시장 규모 (단 : 백만원) ······························································130
[그림Ⅳ-16] 식품첨가물 시장 연도별 포지셔닝 ····································································131
[그림Ⅳ-17] 발효식품 시장 규모 (단 : 백만원) ··································································132
[그림Ⅳ-18] 발효식품 시장 연도별 포지셔닝 ········································································133
[그림Ⅳ-19] 사료첨가제 시장 규모 (단 : 백만원) ······························································134
[그림Ⅳ-20] 사료첨가제 시장 연도별 포지셔닝 ····································································135
[그림Ⅳ-21] 기타 바이오식품 시장 규모 (단 : 백만원) ····················································136
[그림Ⅳ-22] 기타 바이오식품 시장 연도별 포지셔닝 ··························································137
Ⅴ.바이오환경산업 동향 ··································································· 141[그림Ⅴ-1] 바이오환경산업 분류 ······························································································141
[그림Ⅴ-2] 바이오환경 시장 규모 (단 : 백만원) ································································144
[그림Ⅴ-3] 바이오환경 분야별 시장 유율 (단 : 백만원) ················································145
[그림Ⅴ-4] 바이오환경 시장 분야별 포지셔닝 - 2010년 ····················································147
[그림Ⅴ-5] 바이오환경 분야별 국내 매 유율 (단 : 백만원) ····································147
[그림Ⅴ-6] 바이오환경 분야별 국내 매 포지셔닝 - 2010년 ··········································149
[그림Ⅴ-7] 바이오환경 분야별 수출 유율 (단 : 백만원) ··············································150
[그림Ⅴ-8] 바이오환경 분야별 수출 포지셔닝 - 2010년 ····················································151
[그림Ⅴ-9] 바이오환경 분야별 수입 유율 (단 : 백만원) ··············································152
[그림Ⅴ-10] 바이오환경 분야별 수입 포지셔닝 - 2010년 ··················································153
[그림Ⅴ-11] 환경처리용 미생물제제 시장 규모 (단 : 백만원) ········································154
[그림Ⅴ-12] 환경처리용 미생물제제 시장 연도별 포지셔닝 ··············································155
[그림Ⅴ-13] 미생물 고정화소재 설비 시장 규모 (단 : 백만원) ································156
[그림Ⅴ-14] 미생물 고정화소재 설비 시장 연도별 포지셔닝 ······································157
[그림Ⅴ-15] 바이오환경제제 시스템 시장 규모 (단 : 백만원) ··································158
[그림Ⅴ-16] 바이오환경제제 시스템 시장 연도별 포지셔닝 ········································159
[그림Ⅴ-17] 환경오염 측정시스템 시장 규모 (단 : 백만원) ············································160
[그림Ⅴ-18] 환경오염 측정시스템 시장 연도별 포지셔닝 ··················································161
[그림Ⅴ-19] 기타 바이오환경제품 서비스 시장 규모 (단 : 백만원) ························162
24 한국산업마 연구소
[그림Ⅴ-20] 기타 바이오환경제품 서비스 시장 연도별 포지셔닝 ······························163
Ⅵ. 바이오전자산업 동향 ································································· 167[그림Ⅵ-1] 바이오 자산업 분류 ······························································································167
[그림Ⅵ-2] 바이오 자 시장 규모 (단 : 백만원) ································································170
[그림Ⅵ-3] 바이오 자 분야별 시장 유율 (단 : 백만원) ················································171
[그림Ⅵ-4] 바이오 자 시장 분야별 포지셔닝 - 2010년 ····················································172
[그림Ⅵ-5] 바이오 자 분야별 국내 매 유율 (단 : 백만원) ····································173
[그림Ⅵ-6] 바이오 자 분야별 국내 매 포지셔닝 - 2010년 ··········································174
[그림Ⅵ-7] 바이오 자 분야별 수출 유율 (단 : 백만원) ··············································175
[그림Ⅵ-8] 바이오 자 분야별 수출 포지셔닝 - 2010년 ····················································176
[그림Ⅵ-9] 바이오 자 분야별 수입 유율 (단 : 백만원) ··············································177
[그림Ⅵ-10] 바이오 자 분야별 수입 포지셔닝 - 2010년 ··················································178
[그림Ⅵ-11] DNA칩 시장 규모 (단 : 백만원) ·····································································179
[그림Ⅵ-12] DNA칩 시장 연도별 포지셔닝 ···········································································180
[그림Ⅵ-13] 단백질칩 시장 규모 (단 : 백만원) ··································································181
[그림Ⅵ-14] 단백질칩 시장 연도별 포지셔닝 ········································································182
[그림Ⅵ-15] 세포칩 시장 규모 (단 : 백만원) ······································································182
[그림Ⅵ-16] 세포칩 시장 연도별 포지셔닝 ············································································183
[그림Ⅵ-17] 바이오센서 시장 규모 (단 : 백만원) ······························································184
[그림Ⅵ-18] 바이오센서 시장 연도별 포지셔닝 ····································································185
[그림Ⅵ-19] 바이오멤스 시장 규모 (단 : 백만원) ······························································186
[그림Ⅵ-20] 바이오멤스 시장 연도별 포지셔닝 ····································································187
[그림Ⅵ-21] 기타바이오 자제품 시장 규모 (단 : 백만원) ··············································188
[그림Ⅵ-22] 기타바이오 자제품 시장 연도별 포지셔닝 ····················································189
Ⅶ. 바이오공정 및 기기산업 동향 ················································· 193[그림Ⅶ-1] 바이오공정 기기산업 분류 ··············································································193
[그림Ⅶ-2] 바이오공정 기기 시장 규모 (단 : 백만원) ················································196
[그림Ⅶ-3] 바이오공정 기기 분야별 시장 유율 (단 : 백만원) ································197
[그림Ⅶ-4] 바이오공정 기기 시장 분야별 포지셔닝 - 2010년 ····································198
[그림Ⅶ-5] 바이오공정 기기 분야별 국내 매 유율 (단 : 백만원) ····················199
[그림Ⅶ-6] 바이오공정 기기 분야별 국내 매 포지셔닝 - 2010년 ··························201
[그림Ⅶ-7] 바이오공정 기기 분야별 수출 유율 (단 : 백만원) ······························201
[그림Ⅶ-8] 바이오공정 기기 분야별 수출 포지셔닝 - 2010년 ····································203
[그림Ⅶ-9] 바이오공정 기기 분야별 수입 유율 (단 : 백만원) ······························203
[그림Ⅶ-10] 바이오공정 기기 분야별 수입 포지셔닝 - 2010년 ··································205
[그림Ⅶ-11] 바이오반응기 시장 규모 (단 : 백만원) ··························································206
[그림Ⅶ-12] 바이오반응기 시장 연도별 포지셔닝 ································································207
[그림Ⅶ-13] 생체의료기기 진단기 시장 규모 (단 : 백만원) ······································208
25 www.kimr.co.kr
[그림Ⅶ-14] 생체의료기기 진단기 시장 연도별 포지셔닝 ············································209
[그림Ⅶ-15] 바이오공정 분석기기 시장 규모 (단 : 백만원) ······································210
[그림Ⅶ-16] 바이오공정 분석기기 시장 연도별 포지셔닝 ············································211
[그림Ⅶ-17] 공장 공정설계 시장 규모 (단 : 백만원) ··················································212
[그림Ⅶ-18] 공장 공정설계 시장 연도별 포지셔닝 ························································213
[그림Ⅶ-19] 기타 바이오공정 기기 시장 규모 (단 : 백만원) ····································214
[그림Ⅶ-20] 기타 바이오공정 기기 시장 연도별 포지셔닝 ··········································215
Ⅷ. 바이오에너지 및 자원산업 동향 ············································· 219[그림Ⅷ-1] 바이오에 지 자원산업 분류 ··········································································219
[그림Ⅷ-2] 바이오에 지 자원 시장 규모 (단 : 백만원) ············································222
[그림Ⅷ-3] 바이오에 지 자원 분야별 시장 유율 (단 : 백만원) ····························223
[그림Ⅷ-4] 바이오에 지 자원 시장 분야별 포지셔닝 - 2010년 ································224
[그림Ⅷ-5] 바이오에 지 자원 분야별 국내 매 유율 (단 : 백만원) ················225
[그림Ⅷ-6] 바이오에 지 자원 분야별 국내 매 포지셔닝 - 2010년 ······················227
[그림Ⅷ-7] 바이오에 지 자원 분야별 수출 유율 (단 : 백만원) ··························227
[그림Ⅷ-8] 바이오에 지 자원 분야별 수출 포지셔닝 - 2010년 ································228
[그림Ⅷ-9] 바이오에 지 자원 분야별 수입 유율 (단 : 백만원) ··························229
[그림Ⅷ-10] 바이오에 지 자원 분야별 수입 포지셔닝 - 2010년 ······························230
[그림Ⅷ-11] 바이오연료 시장 규모 (단 : 백만원) ······························································231
[그림Ⅷ-12] 바이오연료 시장 연도별 포지셔닝 ····································································232
[그림Ⅷ-13] 인공종자 묘목 시장 규모 (단 : 백만원) ··················································233
[그림Ⅷ-14] 인공종자 묘목 시장 연도별 포지셔닝 ························································234
[그림Ⅷ-15] 실험동물 시장 규모 (단 : 백만원) ··································································235
[그림Ⅷ-16] 실험동물 시장 연도별 포지셔닝 ········································································236
[그림Ⅷ-17] 유 자변형 동식물 시장 규모 (단 : 백만원) ················································237
[그림Ⅷ-18] 유 자변형 동식물 시장 연도별 포지셔닝 ······················································238
[그림Ⅷ-19] 기타 바이오에 지 자원 시장 규모 (단 : 백만원) ································238
Ⅸ. 바이오검정, 정보서비스, 연구개발산업 동향 ······················· 243[그림Ⅸ-1] 바이오검정, 정보서비스 연구개발 산업 분류 ·············································243
[그림Ⅸ-2] 바이오검정, 정보서비스 연구개발 사업 시장 규모 (단 : 백만원) ······· 246